OVERVIEW
Barron's print edition as published September 25, 2023.
On the Cover: THE 50 BILLION DOLLAR QUESTION - The new injectable obesity treatments from Novo Nordisk and Eli Lilly could become so popular that they threaten the healthcare system. Who stands to gain—and lose.
Plus:
- A BRUTAL WEEK FOR STOCKS—WHAT’S NEXT
Vol. CIII No. 39